This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimamoto, H. Articles by Shimamoto, Y. Search for Related Content PubMed PubMed Citation Articles by Shimamoto, H. Articles by Shimamoto, Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Pressure Medicines Hazardous Substances DB LISINOPRIL

(Hypertension. 1996;28:457-463.)
© 1996 American Heart Association, Inc.

Articles

Lisinopril Reverses Left Ventricular Hypertrophy Through Improved Aortic Compliance

Hiroyuki Shimamoto; Yoriko Shimamoto

The Department of Cardiovascular Medicine, PIA Nakamura Hospital, Hiroshima, Japan.

Correspondence to Hiroyuki Shimamoto, MD, 2-24-1, Koi-Higashi, Nishi-ku, Hiroshima 733, Japan.

We treated with nifedipine or lisinopril 38 essential hypertensive patients with left ventricular hypertrophy. The study had a single-blind crossover design; nifedipine or lisinopril was given for the first 24 weeks, and then patients were crossed over to the other antihypertensive agent for another 24 weeks. Both nifedipine and lisinopril significantly decreased mean arterial pressure to the same extent. Although lisinopril decreased left ventricular mass index more rapidly than nifedipine, 48 weeks of antihypertensive treatment with nifedipine or lisinopril reduced the extent of left ventricular hypertrophy to the same level. Stepwise multiple linear regression analysis revealed that the reversal of left ventricular hypertrophy may be mainly due to a reduction in mean arterial pressure during the 24-week nifedipine treatment and due to an improvement of aortic compliance during the lisinopril treatment. Both nifedipine and lisinopril are effective in the reversal of hypertensive left ventricular hypertrophy; however, the agents have disparate actions on hemodynamic factors.

Key Words: lisinopril • hypertrophy, left ventricular • nifedipine • compliance

This article has been cited by other articles:

				R. H. Fagard, H. Celis, L. Thijs, and S. Wouters Regression of Left Ventricular Mass by Antihypertensive Treatment: A Meta-Analysis of Randomized Comparative Studies Hypertension, November 1, 2009; 54(5): 1084 - 1091. [Abstract] [Full Text] [PDF]

				Y. Matsumoto, M. Hamada, and K. Hiwada Aortic Distensibility is Closely Related to the Progression of Left Ventricular Hypertrophy in Patients Receiving Hemodialysis Angiology, November 1, 2000; 51(11): 933 - 941. [Abstract] [PDF]

				P.A. van Zwieten The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy Cardiovasc Res, January 1, 2000; 45(1): 82 - 91. [Abstract] [Full Text] [PDF]

				M. J. Domanski, B. R. Davis, M. A. Pfeffer, M. Kastantin, and G. F. Mitchell Isolated Systolic Hypertension : Prognostic Information Provided by Pulse Pressure Hypertension, September 1, 1999; 34(3): 375 - 380. [Abstract] [Full Text] [PDF]

				D. Schachter and J. C. Sang Aortic leucine-to-glutamate pathway: metabolic route and regulation of contractile responses Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1135 - H1148. [Abstract] [Full Text] [PDF]